We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App





BBQ Lighter, Combined with Microneedles, Sparks Breakthrough in COVID-19 Vaccine Delivery

By HospiMedica International staff writers
Posted on 25 Oct 2021
Print article
Image: The ultra-low-cost ePatch vaccination device (Photo courtesy of Candler Hobbs, Georgia Tech)
Image: The ultra-low-cost ePatch vaccination device (Photo courtesy of Candler Hobbs, Georgia Tech)

Future vaccine delivery may rely on everyday items like BBQ lighters and microneedles, thanks to the ingenuity of a team of researchers.

Researchers at the Georgia Institute of Technology (Atlanta, GA, USA) and Emory University (Atlanta, GA, USA) have developed and tested an innovative method that may simplify the complexity of delivering COVID-19 and other vaccines through a handheld electroporator. While electroporation is commonly employed in the research lab using short electric pulses to drive molecules into cells, the technique currently requires large, complex, and costly equipment, severely limiting its use for vaccine delivery. The new approach does the job using a novel pen-size device that requires no batteries and can be mass produced at low cost.

The inspiration for the research team’s breakthrough came from an everyday device that people use to start a grill: the electronic barbecue lighter. The team took the innards of a lighter and reengineered them into a tiny spring-latch mechanism. The device creates the same electric field in the skin as the large bulky electroporation machines already in use, but using widely available, low-cost components that require no battery to operate. Pairing the reimagined lighter device with microneedle technology from Georgia Tech’s Laboratory for Drug Delivery has resulted in a new ultra-low-cost electroporation system, or “ePatch.”

Besides the lighter, a key innovation involved tightly spacing the electrodes and using extremely short microneedles. While commonly used in cosmetics to rejuvenate skin and for potential medical applications, microneedles are not generally used as electrodes. Coupling the tiny electroporation pulser with microneedle electrodes made an effective electrical interface with the skin and further reduced the ePatch’s cost and complexity. The microneedle-based system uses voltages similar to conventional electroporation but with pulses that are 10,000 times shorter and using electrodes that penetrate just .01 inch into the skin surface.

To find out if their system could be used with a vaccine to generate an immune response, the researchers tested the delivery system first using a florescent protein to ensure it worked, and to deliver an actual COVID-19 vaccine. They selected an experimental DNA vaccine for COVID-19 as their model. Using this method with the same amount of vaccine, the ePatch induced an almost tenfold improved immune response over intramuscular immunization or intradermal injection without electroporation. It also showed no lasting effects to the mice’s skin, indicating that it is easier to achieve protection. The researchers say the ePatch should also work for mRNA vaccination, which they are currently studying.

Today’s genetic vaccines, whether mRNA or DNA, remain expensive as a global solution because they either require a complicated cold chain and costly manufacturing due to the formulation of lipid nanoparticles for mRNA delivery or they need a sophisticated electroporation device for DNA vaccine delivery. But devising a simpler, cost-effective electroporator that works with the DNA vaccine could dramatically reduce the cost and complexity of vaccinations since it does not require deep-freeze storage of mRNA vaccines, which need frigid temperatures because they contain lipid nanoparticles. The researchers are already looking at ways to refine their system, examining how to optimize the immune response on the skin site and integrating the device into one unit.

“Our goal was to design a method for COVID-19 vaccination that uses a device that is simple, low-cost and manufacturable,” said Dengning Xia, lead author on the study while working as a research scientist at Georgia Tech and currently an associate professor at Sun Yat-sen University in China. “The ePatch is a handheld device the size of a pen, weighing less than two ounces, and requiring no battery or power sources. It operates by simply pushing a button, which makes it very simple to use.”

“We know that COVID-19 won’t be the last pandemic,” said Saad Bhamla, assistant professor in the School of Chemical and Biomolecular Engineering. “We need to think from a cost as well as design perspective about how to simplify and scale up our hardware so these modern interventions can be more equitably dispersed - to reach more underserved and more under-resourced areas of the world.”

Related Links:
Georgia Institute of Technology 
Emory University 

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Transvaginal Tube
LiNA McCartney Tube

Print article

Channels

Critical Care

view channel
Image: Researchers have developed an advanced shear-thinning hydrogel for aneurysm repair (Photo courtesy of TIBI)

New Hydrogel Features Enhanced Capabilities for Treating Aneurysms and Halting Progression

Aneurysms can develop in blood vessels in different body areas, often as a result of atherosclerosis, infections, inflammatory diseases, and other risk factors. These conditions lead to chronic inflammation,... Read more

Surgical Techniques

view channel
Image: The living replacement knee will be tested in clinical trials within five years (Photo courtesy of ARPA-H)

Living Knee Replacement to Revolutionize Osteoarthritis Treatment

Osteoarthritis is the most prevalent type of arthritis, characterized by the progressive deterioration of cartilage, or the protective tissue covering the bone ends, resulting in pain, stiffness, and impaired... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The new eye-safe laser technology can diagnose traumatic brain injury (Photo courtesy of 123RF)

Novel Diagnostic Hand-Held Device Detects Known Biomarkers for Traumatic Brain Injury

The growing need for prompt and efficient diagnosis of traumatic brain injury (TBI), a major cause of mortality globally, has spurred the development of innovative diagnostic technologies.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.